نتایج جستجو برای: ibandronate

تعداد نتایج: 387  

Journal: :Journal of Korean Society for Clinical Pharmacology and Therapeutics 2006

Journal: :Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013
Paul D Miller Sophie A Jamal Pieter Evenepoel Richard Eastell Steven Boonen

Bisphosphonates are widely used for the treatment of osteoporosis and are generally well tolerated. However, the United States Food and Drug Administration safety reports have highlighted the issue of renal safety in bisphosphonate-treated patients. All bisphosphonates carry labeled "warnings" or a contraindication for use in patients with severe renal impairment (creatinine clearance <30 or <3...

Journal: :Srpski arhiv za celokupno lekarstvo 2011
Marko Bumbasirević Aleksandar Lesić Ljiljana Denić-Marković Kristina Zivković

INTRODUCTION Osteoporosis is a serious problem, since about 50% of women over the age of 50 suffer at least one osteoporotic fracture. OBJECTIVE The aim of this study was to evaluate compliance as well as the efficiency and safety of ibandronate treatment over a 6-month period in reducing the risk of subsequent fracture in women with postmenopausal osteoporosis. METHODS A multicenter, prosp...

Journal: :Journal of prosthodontics : official journal of the American College of Prosthodontists 2018
Sergio Varela Kellesarian Tariq Abduljabbar Fahim Vohra Elham Gholamiazizi Hans Malmstrom Georgios E Romanos Fawad Javed

PURPOSE To our knowledge from indexed literature, the present study is the first one to systematically review the influence of local delivery of pamidronate (PAM) and/or ibandronate (IBA) on osseointegration enhancement. The aim of the present systematic review was to assess the efficacy of IBA and/or PAM local delivery (topically or coating on implants surfaces) in promoting osseointegration. ...

2006
Jean-Yves Reginster Véronique Rabenda

The leading treatments for postmenopausal osteoporosis are the nitrogen-containing bisphosphonates, which are required long term for optimal benefit. Oral bisphosphonates have proven efficacy in postmenopausal osteoporosis in clinical trials, but in practice the therapeutic benefits are often compromised by patients' low adherence. Nonadherence to bisphosphonate therapy negatively impacts outco...

2012
Daniel Kaemmerer Benjamin Schmidt Gabriele Lehmann Gunter Wolf Utz Settmacher Merten Hommann

UNLABELLED BACKGROUND Most of the patients awaiting liver transplantation already have osteopenia or even osteoporosis by end-stage liver disease.In a retrospective study, we investigated the effect of pre-treatment with oral monthly ibandronate (150 mg), vitamin D3 (800 IU/day) and calcium (1 g/day) for osteopenia and osteoporosis caused by end-stage liver disease in patients before and aft...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید